Sleep Apnea in Patients with MGUS and MM

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

This study involves patients with plasma cell dyscrasia including monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM), with and without sleep apnea, who are providing bone marrow specimens. Specimens will be obtained at the time that patients undergo a standard-of-care procedure in order to minimize discomfort and reduce any risk.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• Patients diagnosed with MGUS or MM who will be receiving a bone marrow biopsy as part of their standard of care are eligible to participate in this study

Locations
United States
Iowa
University of Iowa
RECRUITING
Iowa City
Contact Information
Primary
Michael Tomasson, MD
michael-tomasson@uiowa.edu
319-356-4200
Time Frame
Start Date: 2019-05-23
Estimated Completion Date: 2025-05-23
Participants
Target number of participants: 200
Treatments
A. patients with MGUS and sleep apnea
B. patients with MGUS and no sleep apnea
C. patients with MM and sleep apnea
D. patients with MM and no sleep apnea
Authors
Melissa Bates
Sponsors
Leads: Michael Tomasson
Collaborators: Department of Health and Human Services

This content was sourced from clinicaltrials.gov